Cost Comparison of Psoriasis Treatments

Mikhael, Dalia M.; Babcock, Kelly; DesGroseilliers, Jean-Pierre

doi:10.2310/7750.2009.08088

Cited by 2 publications

(1 citation statement)

References 1 publication

(2 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Economically, compared with whole-body phototherapy or biologics, localized phototherapy is more affordable for physicians and relatively less costly for patients given the fewer number of treatment sessions. [30][31][32][33] Provided these advantages, localized phototherapy should be considered among the treatment options for localized variants of psoriasis, such as the plaque and palmoplantar pustular types.…”

Section: Discussionmentioning

confidence: 99%

A review of targeted ultraviolet B phototherapy for psoriasis

Mudigonda

Dabade

Feldman

2012

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A review of targeted ultraviolet B phototherapy for psoriasis

Mudigonda

Dabade

Feldman

2012

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

A Practical Approach to the Use of Methotrexate

Busse

Koo

2010

Psoriasis Forum

View full text Add to dashboard Cite

Background Methotrexate is approved by the Food and Drug Ad ministration for the treatment of severe, recalcitrant, and disabling psoriasis that is not adequately responsive to other forms of therapy. It is a systemic immunosuppressant that requires appropriate patient selection, screening laboratory values, and close monitoring before initiation of a maintenance regimen. Purpose This clinical review outlines a practical approach for the use of methotrexate in psoriasis. Methods A review of English-language literature between 1950 and 2010 was conducted, and the results are presented here. Results With close monitoring and appropriate patient selection, methotrexate is often an effective treatment option for moderate to severe psoriasis. Attention to individual patient risk factors and understanding of dosing regimens, contraindications, and “black box” warnings regarding methotrexate use can assist dermatologists in safely prescribing methotrexate for psoriasis treatment. Limitations This practical approach is based on an extensive literature review and the National Psoriasis Foundation and American Academy of Dermatology guidelines formulated after years of clinical practice, newer efficacy trials, and expert consensus regarding management in psoriasis patients. We have additionally incorporated some recommendations from our clinical experience at the University of California-San Francisco Psoriasis Treatment Center as indicated in the text. As always, clinical judgment and risk assessment should be used in selecting appropriate psoriasis patients for methotrexate therapy. Conclusion Methotrexate remains an effective, less expensive, and safe option for psoriasis patients who were previously unresponsive to other forms of therapy.

show abstract

Cost Comparison of Psoriasis Treatments

Abstract: With the knowledge of these data, informed prescribing by the dermatologist may reduce the financial burden to the patient, the provincial health care system, and insurance companies.

Cited by 2 publications

References 1 publication

A review of targeted ultraviolet B phototherapy for psoriasis

A review of targeted ultraviolet B phototherapy for psoriasis

A Practical Approach to the Use of Methotrexate

Contact Info

Product

Resources

About